Assessment of Cardiovascular Risk Factors and Their Interactions in the Risk of Coronary Heart Disease in Patients with Type 2 Diabetes with Different Weight Levels, 2013–2018

References

• Haffner S , Lehto S , Rönnemaa T , Pyörälä K , Laakso M . Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med . 1998;339(4):229–234. doi:10.1056/nejm199807233390404 9673301
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA . 2001;285(19):2486–2497. doi:10.1001/jama.285.19.2486.11368702
   PubMed Web of Science ®Google Scholar
• Ali Raza J , Movahed A . Current concepts of cardiovascular diseases in diabetes mellitus. Int J Cardiol . 2003;89:123–134. doi:10.1016/s0167-5273(02)00510-7 12767534
   PubMed Web of Science ®Google Scholar
• Lee J , Ma S , Heng D , Chew S , Hughes K , Tai E . Hypertension, concurrent cardiovascular risk factors and mortality: the Singapore Cardiovascular Cohort Study. J Hum Hypertens . 2008;22(7):468–474. doi:10.1038/jhh.2008.16 18337755
   PubMed Web of Science ®Google Scholar
• Chen G , McAlister F , Walker R , Hemmelgarn B , Campbell N . Cardiovascular outcomes in Framingham participants with diabetes: the importance of blood pressure. Hypertension . 2011;57(5):891–897. doi:10.1161/hypertensionaha.110.162446 21403089
   PubMed Web of Science ®Google Scholar
• Lehto S , Rönnemaa T , Pyörälä K , Laakso M . Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with type II diabetes. Diabetologia . 2000;43(2):148–155. doi:10.1007/s001250050023 10753035
   PubMed Web of Science ®Google Scholar
• Chung W , Erion K , Florez J , et al. Precision medicine in diabetes: a consensus report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care . 2020;43(7):1617–1635. doi:10.2337/dci20-0022 32561617
   PubMed Web of Science ®Google Scholar
• Patel A , MacMahon S , Chalmers J , et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med . 2008;358(24):2560–2572. doi:10.1056/NEJMoa0802987 18539916
   PubMed Web of Science ®Google Scholar
• Gerstein H , Miller M , Byington R , et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med . 2008;358(24):2545–2559. doi:10.1056/NEJMoa0802743 18539917
   PubMed Web of Science ®Google Scholar
• Zhao D , Liu J , Xie W , Qi Y . Cardiovascular risk assessment: a global perspective. Nat Rev Cardiol . 2015;12(5):301–311. doi:10.1038/nrcardio.2015.28 25754885
   PubMed Web of Science ®Google Scholar
• Timpka S , Stuart J , Tanz L , Hu F , Franks P , Rich-Edwards J . Postpregnancy BMI in the progression from hypertensive disorders of pregnancy to type 2 diabetes. Diabetes Care . 2019;42(1):44–49. doi:10.2337/dc18-1532 30455328
   PubMed Web of Science ®Google Scholar
• Timpka S , Stuart J , Tanz L , Rimm E , Franks P , Rich-Edwards J . Lifestyle in progression from hypertensive disorders of pregnancy to chronic hypertension in Nurses’ Health Study II: observational cohort study. BMJ . 2017;358:j3024. doi:10.1136/bmj.j3024 28701338
   PubMed Web of Science ®Google Scholar
• Feldstein C , Julius S . The complex interaction between overweight, hypertension, and sympathetic overactivity. J Am Soc Hypertens . 2009;3(6):353–365. doi:10.1016/j.jash.2009.10.001 20409978
   PubMed Web of Science ®Google Scholar
• Musameh M , Wang W , Nelson CP , et al. Analysis of gene-gene interactions among common variants in candidate cardiovascular genes in coronary artery disease. PLoS One . 2015;10(2):e0117684. doi:10.1371/journal.pone.0117684 25658981
   PubMed Web of Science ®Google Scholar
• Napoli C , Benincasa G , Schiano C , Salvatore M . Differential epigenetic factors in the prediction of cardiovascular risk in diabetic patients. Eur Heart J Cardiovasc Pharmacother . 2020;6(4):239–247. doi:10.1093/ehjcvp/pvz062 31665258
   PubMed Web of Science ®Google Scholar
• Song Y , Shan Z , Liu X , et al. An updated meta-analysis showed smoking modify the association of GSTM1 null genotype on the risk of coronary heart disease. Biosci Rep . 2021;41(2). doi:10.1042/bsr20200490
   Web of Science ®Google Scholar
• Wang C , Lê-Scherban F , Taylor J , et al. Associations of job strain, stressful life events, and social strain with coronary heart disease in the Women’s Health initiative observational study. J Am Heart Assoc . 2021;10(5):e017780. doi:10.1161/jaha.120.017780 33618543
   PubMed Web of Science ®Google Scholar
• Andersson T , Alfredsson L , Källberg H , Zdravkovic S , Ahlbom A . Calculating measures of biological interaction. Eur J Epidemiol . 2005;20(7):575–579. doi:10.1007/s10654-005-7835-x 16119429
   PubMed Web of Science ®Google Scholar
• Kivimäki M , Kuosma E , Ferrie J , et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health . 2017;2(6):e277–e285. doi:10.1016/s2468-2667(17)30074-9 28626830
   PubMed Web of Science ®Google Scholar
• Dale C , Fatemifar G , Palmer T , et al. Causal associations of adiposity and body fat distribution with coronary heart disease, stroke subtypes, and type 2 diabetes mellitus: a Mendelian randomization analysis. Circulation . 2017;135(24):2373–2388. doi:10.1161/circulationaha.116.026560 28500271
   PubMed Web of Science ®Google Scholar
• Larsson S , Bäck M , Rees J , Mason A , Burgess S . Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study. Eur Heart J . 2020;41(2):221–226. doi:10.1093/eurheartj/ehz388 31195408
   PubMed Web of Science ®Google Scholar
• Doehner W , Gerstein H , Ried J , et al. Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial. Eur Heart J . 2020;41(28):2668–2677. doi:10.1093/eurheartj/ehaa293 32402060
   PubMed Web of Science ®Google Scholar
• Hansel B , Roussel R , Elbez Y , et al. Cardiovascular risk in relation to body mass index and use of evidence-based preventive medications in patients with or at risk of atherothrombosis. Eur Heart J . 2015;36(40):2716–2728. doi:10.1093/eurheartj/ehv347 26242715
   PubMed Web of Science ®Google Scholar
• Luijckx E , Lohse T , Faeh D , Rohrmann S . Joints effects of BMI and smoking on mortality of all-causes, CVD, and cancer. Cancer Causes Control . 2019;30(5):549–557. doi:10.1007/s10552-019-01160-8 30911976
   PubMed Web of Science ®Google Scholar
• Doehner W . Critical appraisal of the obesity paradox in cardiovascular disease: how to manage patients with overweight in heart failure? Heart Fail Rev . 2014;19(5):637–644. doi:10.1007/s10741-014-9425-z 24554113
   PubMed Web of Science ®Google Scholar
• Lavie C , McAuley P , Church T , Milani R , Blair S . Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol . 2014;63(14):1345–1354. doi:10.1016/j.jacc.2014.01.022 24530666
   PubMed Web of Science ®Google Scholar
• Elagizi A , Kachur S , Lavie C , et al. An overview and update on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis . 2018;61(2):142–150. doi:10.1016/j.pcad.2018.07.003 29981771
   PubMed Web of Science ®Google Scholar
• Eckel N , Meidtner K , Kalle-Uhlmann T , Stefan N , Schulze M . Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis. Eur J Prev Cardiol . 2016;23(9):956–966. doi:10.1177/2047487315623884 26701871
   PubMed Web of Science ®Google Scholar
• Kramer C , Zinman B , Retnakaran R . Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med . 2013;159(11):758–769. doi:10.7326/0003-4819-159-11-201312030-00008 24297192
   PubMed Web of Science ®Google Scholar
• Lassale C , Tzoulaki I , Moons K , et al. Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis. Eur Heart J . 2018;39(5):397–406. doi:10.1093/eurheartj/ehx448 29020414
   PubMed Web of Science ®Google Scholar
• Caleyachetty R , Thomas G , Toulis K , et al. Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women. J Am Coll Cardiol . 2017;70(12):1429–1437. doi:10.1016/j.jacc.2017.07.763 28911506
   PubMed Web of Science ®Google Scholar
• Rothman KJ , Greenland S , Lash TL . Modern Epidemiology . 3rd ed. Philadelphia: Wolters KIuwer, Lippincott Williams and Wilhns; 2008.
   Google Scholar
• Rumantir M , Kaye D , Jennings G , Vaz M , Hastings J , Esler M . Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension. Hypertension . 2000;36(5):824–829. doi:10.1161/01.hyp.36.5.824 11082150
   PubMed Web of Science ®Google Scholar
• Esler M , Wallin G , Dorward P , et al. Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. Am J Physiol . 1991;260:R817–R823. doi:10.1152/ajpregu.1991.260.4.R817 2012253
   PubMed Web of Science ®Google Scholar
• Lichtor T , Davis H , Johns L , Vesselinovitch D , Wissler R , Mullan S . The sympathetic nervous system and atherosclerosis. J Neurosurg . 1987;67(6):906–914. doi:10.3171/jns.1987.67.6.0906 3681430
   PubMed Web of Science ®Google Scholar
• Amiya E , Watanabe M , Komuro I . The Relationship between Vascular Function and the Autonomic Nervous System. Ann Vasc Dis . 2014;7(2):109–119. doi:10.3400/avd.ra.14-00048 24995054
   PubMedGoogle Scholar
• Vesa C , Popa L , Popa A , et al. Current data regarding the relationship between type 2 diabetes mellitus and cardiovascular risk factors. Diagnostics . 2020;10(5):314. doi:10.3390/diagnostics10050314
   Web of Science ®Google Scholar
• Iorga RA , Bacalbasa N , Carsote M , et al. Metabolic and cardiovascular benefits of GLP-1 agonists, besides the hypoglycemic effect. Exp Ther Med . 2020;20(3):2396–2400. doi:10.3892/etm.2020.8714 32765722
   PubMed Web of Science ®Google Scholar